Cited by 1,107Nanoparticle-Based Drug DeliveryBarrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.

Nanoparticulate systems for brain delivery of drugs.

Kreuter, Jörg·2001·Advanced Drug Delivery Reviews

DOI 10.1016/s0169-409x(00)00122-8

Open this paper in CoChat — free account

Abstract

The blood--brain barrier (BBB) represents an insurmountable obstacle for a large number of drugs, including antibiotics, antineoplastic agents, and a variety of central nervous system (CNS)-active drugs, especially neuropeptides. One of the possibilities to overcome this barrier is a drug delivery to the brain using nanoparticles. Drugs that have successfully been transported into the brain using this carrier include the hexapeptide dalargin, the dipeptide kytorphin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and doxorubicin. The nanoparticles may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. Intravenously injected doxorubicin-loaded polysorbate 80-coated nanoparticles were able to lead to a 40% cure in rats with intracranially transplanted glioblastomas 101/8. The mechanism of the nanoparticle-mediated transport of the drugs across the blood-brain barrier at present is not fully elucidated. The most likely mechanism is endocytosis by the endothelial cells lining the brain blood capillaries. Nanoparticle-mediated drug transport to the brain depends on the overcoating of the particles with polysorbates, especially polysorbate 80. Overcoating with these materials seems to lead to the adsorption of apolipoprotein E from blood plasma onto the nanoparticle surface. The particles then seem to mimic low density lipoprotein (LDL) particles and could interact with the LDL receptor leading to their uptake by the endothelial cells. After this the drug may be released in these cells and diffuse into the brain interior or the particles may be transcytosed. Other processes such as tight junction modulation or P-glycoprotein (Pgp) inhibition also may occur. Moreover, these mechanisms may run in parallel or may be cooperative thus enabling a drug delivery to the brain.

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(00)00122-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli
Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352

Show all 50 references

Research works printed but not linked: 6

Kreuter, 1994, Nanoparticles, Vol. 10, 165
Alyautdin, 1995, Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles, Eur. J. Pharm. Biopharm., 41, 44
Ramge, 2000, Polysorbate 80-coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human, bovine and murine primary brain capilary endothelial cells, Eur. J. Neuro., 12, 1935
Steiniger, 1999, The influence of polysorbate 80-coated nanoparticles on bovine brain capillary endothelial cells in vitro, Proc. Int. Symp. Control. Rel. Bioact. Mater., 26, 789
Fenart, 1999, Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood–brain barrier, J. Pharmacol. Exp. Ther., 291, 1017
Cecchelli, 1997, Receptor-mediated transcytosis of blood-borne molecules through blood–brain barrier endothelial cells: Drug targeting by endogenous transport routes, Proc. Intl. Symp. Control. Rel. Bioact. Mater., 24, 221

Sorted by citations

Items 101–200 of 1,000

Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters
Shah, B. M., Khunt, D., Bhatt, H., Misra, M., & Padh, H. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.07.002 · Cited by 237
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting
Brigger, I., Morizet, J., Aubert, G., Chacun, H., Terrier‐Lacombe, M., Couvreur, P., & Vassal, G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039669 · Cited by 239
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K., & von Briesen, H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.038 · Cited by 234
Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123
Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 236
Spinal Cord Injury: A Review of Current Therapy, Future Treatments, and Basic Science Frontiers
Varma, A. K., Das, A., Wallace, G., Barry, J., Vertegel, A. A., Ray, S. K., & Banik, N. L. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0991-6 · Cited by 233
Polymeric nanoparticles for the drug delivery to the central nervous system
Tosi, G., Costantino, L., Ruozi, B., Forni, F., & Vandelli, M. A. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.2.155 · Cited by 242
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Patel, R. J., Ajazuddin, M., Ravichandiran, V., Murty, U. S., & Alexander, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.020 · Cited by 239
Natural Gum Reduced/Stabilized Gold Nanoparticles for Drug Delivery Formulations
Dhar, S., Reddy, E. M., Shiras, A., Pokharkar, V., & Prasad, B. L. V. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200801093 · Cited by 227
Magnetic targeting of nanoparticles across the intact blood–brain barrier
Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 229
From molecular biology to nanotechnology and nanomedicine
Bogunia‐Kubik, K., & Sugisaka, M. (2002) · Biosystems · doi:10.1016/s0303-2647(02)00010-2 · Cited by 226
Targeted Nanomedicines: Effective Treatment Modalities for Cancer, AIDS and Brain Disorders
Muthu, M. S., & Singh, S. K. (2008) · Nanomedicine · doi:10.2217/17435889.4.1.105 · Cited by 225
Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers
Poovaiah, N., Davoudi, Z., Peng, H., Schlichtmann, B. W., Mallapragada, S. K., Narasimhan, B., & Wang, Q. (2018) · Nanoscale · doi:10.1039/c8nr04073g · Cited by 231
Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents
Feng, J., Liu, X., Li, L., Mallapragada, S. K., Narasimhan, B., & Wang, Q. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.012 · Cited by 224
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
Kurakhmaeva, K. B., Djindjikhashvili, I. A., Petrov, V. E., Balabanyan, V. U., Voronina, T. A., Trofimov, S. S., Kreuter, J., Gelperina, S., Begley, D., & Alyautdin, R. N. (2009) · Journal of Drug Targeting · doi:10.1080/10611860903112842 · Cited by 221
Biomaterials for the central nervous system
Zhong, Y., & Bellamkonda, R. V. (2008) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0071 · Cited by 221
Nanoparticle Delivery Systems in Cancer Vaccines
Krishnamachari, Y., Geary, S. M., Lemke-Miltner, C. D., & Salem, A. K. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0241-4 · Cited by 225
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier
Krol, S., Macrez, R., Docagne, F., Defer, G. L., Laurent, S., Rahman, M., Hajipour, M. J., Kehoe, P. G., & Mahmoudi, M. (2012) · Chemical Reviews · doi:10.1021/cr200472g · Cited by 219
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
Sun, W., Xie, C., Wang, H., & Hu, Y. L. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.087 · Cited by 215
Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems
Reis, C. P., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.04.009 · Cited by 214
Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
Liu, S., Yang, S., & Ho, P. C. (2017) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.09.001 · Cited by 215
Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain
Wang, Z. H., Wang, Z., Sun, C., Wang, C. Y., Jiang, T., & Wang, S. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.104 · Cited by 214
Potential neurotoxicity of nanoparticles
Hu, Y., & Gao, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.026 · Cited by 218
Glutathione and Parkinson's disease: Is this the elephant in the room?
Zeevalk, G. D., Razmpour, R., & Bernard, L. P. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.017 · Cited by 217
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
Souto, E. B., & Müller, R. H. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 217
Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation
Chugh, V., Krishna, K. V., & Pandit, A. S. (2021) · ACS Nano · doi:10.1021/acsnano.1c03800 · Cited by 219
Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis
Yang, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0141-7 · Cited by 210
Can Controversial Nanotechnology Promise Drug Delivery?
Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R. (2012) · Chemical Reviews · doi:10.1021/cr300047q · Cited by 215
Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
Costantino, L., Gandolfi, F., Tosi, G., Rivasi, F., Vandelli, M. A., & Forni, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.013 · Cited by 213
Cleaner nanotechnology and hazard reduction of manufactured nanoparticles
Reijnders, L. (2005) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2005.03.018 · Cited by 208
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204
Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier
Gan, C. W., & Feng, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.053 · Cited by 205
Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity
Raj, R., Wairkar, S., Sridhar, V., & Gaud, R. S. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.056 · Cited by 205
Solid Lipid Nanoparticles (SLN): Method, Characterization and Applications
Garud, A., Singh, D., & Garud, N. (2012) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v1i11.12065 · Cited by 203
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats
Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert‐Pouëssel, A., Denizot, B., Meneï, P., & Benoît, J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0289 · Cited by 213
Nanotechnology-based systems for the treatment and prevention of HIV/AIDS
das Neves, J., Amiji, M. M., Bahia, M. F., & Sarmento, B. F. C. C. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.017 · Cited by 197
Nanoparticulate Systems for Growth Factor Delivery
Zhang, S., & Uludağ, H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9897-z · Cited by 196
Gelatin nanoparticles: a potential candidate for medical applications
Yasmin, R., Shah, M., Khan, S. A., & Ali, R. (2016) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0009 · Cited by 204
Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line
Chattopadhyay, N., Zastre, J. A., Wong, H. L., Wu, X. Y., & Bendayan, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9615-2 · Cited by 194
Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles
Lin, X., Tian, Wei, Feng, Huang, Wang, Ren, R., & Diao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16570 · Cited by 189
Health effects of inhaled engineered and incidental nanoparticles
Madl, A. K., & Pinkerton, K. E. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440903133788 · Cited by 191
Comparing the effectiveness of chitosan and nanochitosan coatings on the quality of refrigerated silver carp fillets
Ramezani, Z., Zarei, M., & Raminnejad, N. (2014) · Food Control · doi:10.1016/j.foodcont.2014.11.015 · Cited by 186
Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies
Smith, M. W., & Gumbleton, M. (2006) · Journal of drug targeting · doi:10.1080/10611860600650086 · Cited by 192
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 193
Toward the Emergence of Nanoneurosurgery: Part III—Nanomedicine: Targeted Nanotherapy, Nanosurgery, and Progress Toward the Realization of Nanoneurosurgery
Leary, S. P., Liu, C. Y., & Apuzzo, M. L. J. (2006) · Neurosurgery · doi:10.1227/01.neu.0000217016.79256.16 · Cited by 184
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
Esposito, E., Fantin, M., Marti, M., Drechsler, M., Paccamiccio, L., Mariani, P., Sivieri, E., Lain, F., Menegatti, E., Morari, M., et al. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9514-y · Cited by 183
Translocation of Poly(ethylene glycol-co-hexadecyl)cyanoacrylate Nanoparticles into Rat Brain Endothelial Cells: Role of Apolipoproteins in Receptor-Mediated Endocytosis
Kim, H. R., Andrieux, K., Gil, S., Taverna, M., Chacun, H., Desmaële, D., Taran, F., Georgin, D., & Couvreur, P. (2007) · Biomacromolecules · doi:10.1021/bm060711a · Cited by 170
Nanomaterials for Reducing Amyloid Cytotoxicity
Zhang, M., Mao, X., Yu, Y., Wang, C.-X., Yang, Y., & Wang, C. (2013) · Advanced Materials · doi:10.1002/adma.201301210 · Cited by 183
Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain
Fu, H., Muenzer, J., Samulski, R. J., Breese, G. R., Sifford, J., Zeng, X., & McCarty, D. M. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.021 · Cited by 185
Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles
Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment
Loureiro, J. A., Gomes, B., Fricker, G., Coelho, M. A. N., Rocha, S., & Pereira, M. D. C. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.041 · Cited by 185
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
Liu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G. L., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 177
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 169
Ten Things You Might Not Know about Iron Oxide Nanoparticles
Daldrup-Link, H. E. (2017) · Radiology · doi:10.1148/radiol.2017162759 · Cited by 181
Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina
Kim, H., Robinson, S. B., & Csaky, K. G. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9745-6 · Cited by 174
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
Bondì, M. L., Craparo, E. F., Giammona, G., & Drago, F. (2010) · Nanomedicine · doi:10.2217/nnm.09.67 · Cited by 175
Nanoparticles for cancer therapy and diagnosis
Fukumori, Y., & Ichikawa, H. (2005) · Advanced Powder Technology · doi:10.1163/156855206775123494 · Cited by 175
Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke
Sifat, A. E., Vaidya, B., & Abbruscato, T. J. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0091-7 · Cited by 173
Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).
Kreuter, J. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692491 · Cited by 172
Self-citation
Nanotechnological applications for the treatment of neurodegenerative disorders
Modi, G., Pillay, V., Choonara, Y. E., Ndesendo, V. M. K., du Toit, L. C., & Naidoo, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.05.002 · Cited by 174
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery
Kim, W., Ly, N. K., He, Y., Li, Y., Yuan, Z., & Yeo, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114635 · Cited by 176
Current strategies for engineering drug nanoparticles
Date, A. A., & Patravale, V. B. (2004) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2004.06.009 · Cited by 171
Advances in the treatment of neurodegenerative disorders employing nanotechnology
Modi, G., Pillay, V., & Choonara, Y. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05108.x · Cited by 166
Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
Gao, H., Pang, Z., & Jiang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1122-4 · Cited by 167
Nanoparticulate drug delivery systems for cancer chemotherapy
Saha, R. N., Sekar, V., Bende, G., & Snehalatha, M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.510804 · Cited by 163
Nanotechnology-based Drug Delivery for Cancer
Jain, K. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400408 · Cited by 162
Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers
Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162
Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model
Bernardi, A., Braganhol, E., Jäger, E., Figueiró, F., Edelweiss, M. I. A., Pohlmann, A. R., Guterres, S. S., & Battastini, A. M. O. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.018 · Cited by 161
Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma
Fu, S., Liang, M., Wang, Y., Cui, L., Gao, C., Chu, X., Liu, Q., Feng, Y., Gong, W., Yang, M., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18664 · Cited by 161
The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction
Bai, N., Khazaei, M., van Eeden, S. F., & Laher, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.06.005 · Cited by 156
Nanoparticle and other metal chelation therapeutics in Alzheimer disease
Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 160
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology
Mittal, G., Carswell, H. V. O., Brett, R. R., Currie, S., & Kumar, M. N. V. R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.013 · Cited by 157
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer’s disease: Limitations, and current and future perspectives
Fasae, K. D., Abolaji, A. O., Faloye, T. R., Odunsi, A., Oyetayo, B. O., Enya, J. I., Rotimi, J. A., Akinyemi, R., Whitworth, A. J., & Aschner, M. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126779 · Cited by 161
Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles
Bhandari, R., & Kaur, I. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.042 · Cited by 156
Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM)
Liu, Y., & Feng, N. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.04.006 · Cited by 156
Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease
Gupta, J., Fatima, M. T., Islam, Z., Khan, R. H., Uversky, V. N., & Salahuddin, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.156 · Cited by 163
In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors
Koziara, J. M., Whisman, T. R., Tseng, M. T., & Mumper, R. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.001 · Cited by 155
Modification of nanostructured materials for biomedical applications
Xu, T., Zhang, N., Nichols, H. L., Shi, D., & Wen, X. (2006) · Materials Science and Engineering C · doi:10.1016/j.msec.2006.05.029 · Cited by 155
Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain
Prabhakar, K., Afzal, S. M., Surender, G., & Kishan, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.08.001 · Cited by 136
Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine
Kim, S. S., Harford, J. B., Pirollo, K. F., & Chang, E. H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.137 · Cited by 155
Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration
Xia, H., Gao, X., Gu, G., Liu, Z., Zeng, N., Hu, Q., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.004 · Cited by 152
Environmental contaminant–mixture effects on CNS development, plasticity, and behavior
Wormley, D. D., Ramesh, A., & Hood, D. B. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.016 · Cited by 156
Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles
Picone, P., Bondì, M. L., Picone, P., Bondì, M. L., Montana, G., Bruno, A., Pitarresi, G. L., Giammona, G., & Carlo, M. D. (2009) · Free Radical Research · doi:10.1080/10715760903214454 · Cited by 156
Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system
Kim, H. R., Andrieux, K., Deloménie, C., Chacun, H., Appel, M., Desmaële, D., Taran, F., Georgin, D., Couvreur, P., & Taverna, M. (2007) · Electrophoresis · doi:10.1002/elps.200600694 · Cited by 152
Novel Functionalized Biodegradable Polymers for Nanoparticle Drug Delivery Systems
Kallinteri, P., Higgins, S. J., Hutcheon, G. A., Pourçain, C. B. S., & Garnett, M. C. (2005) · Biomacromolecules · doi:10.1021/bm049200j · Cited by 150
Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer
Jain, A., Jain, A., Garg, N. K., Tyagi, R. K., Singh, B., Katare, O. P., Webster, T. J., & Soni, V. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.06.027 · Cited by 145
Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers
Geldenhuys, W. J., Mbimba, T., Bui, T., Harrison, K. A., & Sutariya, V. B. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.589435 · Cited by 144
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Liu, X., Jiao, B., & Shen, L. H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00579 · Cited by 153
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
Awad, R., Avital, A., & Sosnik, A. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.003 · Cited by 150
Pharmacokinetics and Tissue Distribution of Idarubicin-Loaded Solid Lipid Nanoparticles After Duodenal Administration to Rats
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Blood–brain barrier and chemotherapeutic treatment of brain tumors
de Vries, N. A., Beijnen, J. H., Boogerd, W. J., & van Tellingen, O. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.8.1199 · Cited by 142
Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration
Martins, S. M., Sarmento, B. F. C. C., Nunes, C., Lúcio, M., Reis, S., & Ferreira, D. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.011 · Cited by 140
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Rabiee, N., Ahmadi, S., Afshari, R., Khalaji, S., Rabiee, M., Bagherzadeh, M., Fatahi, Y., Dinarvand, R., Tahriri, M., Tayebi, L., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000076 · Cited by 144
Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis
Olano, C., Méndez, C., & Salas, J. A. (2009) · Natural Product Reports · doi:10.1039/b822528a · Cited by 141
Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice
Pradal, J., Maudens, P., Gabay, C., Seemayer, C. A., Jordan, O., & Allémann, É. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.015 · Cited by 140
Biocompatibility of Biomaterials for Nanoencapsulation: Current Approaches
Witika, B. A., Makoni, P. A., Matafwali, S. K., Chabalenge, B., Mwila, C., Kalungia, A. C., Nkanga, C. I., Bapolisi, A. M., & Walker, R. B. (2020) · Nanomaterials · doi:10.3390/nano10091649 · Cited by 150
Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations
Tsai, M.-J., Huang, Y.-B., Wu, P.-C., Fu, Y.-S., Kao, Y.-R., Fang, J.-Y., & Tsai, Y.-H. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22285 · Cited by 137
Preparation, characterization,in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting
Md, S., Ali, M., Baboota, S., Sahni, J. K., Bhatnagar, A., & Ali, J. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.758130 · Cited by 138
In Vitro and in Vivo Studies on the Transport of PEGylated Silica Nanoparticles across the Blood–Brain Barrier
Liu, D., Lin, B., Shao, W., Zhu, Z., Ji, T., & Yang, C. J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am405219u · Cited by 135

Authors: Kreuter, J.
Affiliations: Goethe University Frankfurt (DE)
Corresponding author: Kreuter, Jörg
Venue: Advanced Drug Delivery Reviews
Publisher: Elsevier BV
Published: 2001-03
Volume: 47
Issue: 1
Pages: 65-81
ISSN: 0169-409X (ISSN-L)
DOI: 10.1016/s0169-409x(00)00122-8
OpenAlex: W2072229818
Cited by: 1,107
References: 50
Citations by year: 2026: 15 · 2025: 20 · 2024: 26 · 2023: 39 · 2022: 32 · 2021: 43 · 2020: 47 · 2019: 40 · 2018: 47 · 2017: 53 · 2016: 63 · 2015: 57 · 2014: 55 · 2013: 65 · 2012: 76
FWCI: 1.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advanced Drug Delivery Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, nanoparticle drug delivery, brain drug delivery, apolipoprotein E, glioblastoma, doxorubicin, neuropeptides, P-glycoprotein inhibition, tight junction modulation, transcytosis, central nervous system drugs
MeSH terms: Animals, Antineoplastic Agents, Blood-Brain Barrier, Brain, Brain Neoplasms, Capsules, Cells, Cultured, Doxorubicin, Drug Carriers, Endothelium, Vascular, Humans, Male, Polysorbates, Surface-Active Agents, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticulate systems for brain delivery of drugs.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks